169 related articles for article (PubMed ID: 9538122)
1. Usefulness of K-ras gene mutation at codon 12 in bile for diagnosing biliary strictures.
Ito R; Tamura K; Ashida H; Nishiwaki M; Nishioka A; Yamamoto Y; Furuyama JI; Utsunomiya J
Int J Oncol; 1998 May; 12(5):1019-23. PubMed ID: 9538122
[TBL] [Abstract][Full Text] [Related]
2. Detection of point mutations in K-ras gene at codon 12 in bile from percutaneous transhepatic choledochal drainage tubes for diagnosis of biliary strictures.
Ajiki T; Onoyama H; Yamamoto M; Fujimori T; Maeda S; Saitoh Y
Int J Pancreatol; 1995 Dec; 18(3):215-20. PubMed ID: 8708392
[TBL] [Abstract][Full Text] [Related]
3. Ki-ras mutations in codon 12 and p53 mutations (biomarkers) and cytology in bile in patients with hepatobiliary-pancreatic carcinoma.
Yamaguchi K; Nakano K; Nagai E; Chijiiwa K; Kinoshita M; Ohta M; Tanaka M
Hepatogastroenterology; 2005; 52(63):713-8. PubMed ID: 15966189
[TBL] [Abstract][Full Text] [Related]
4. Analysis of ras gene mutations in biliary and pancreatic tumors by polymerase chain reaction and direct sequencing.
Tada M; Yokosuka O; Omata M; Ohto M; Isono K
Cancer; 1990 Sep; 66(5):930-5. PubMed ID: 2167148
[TBL] [Abstract][Full Text] [Related]
5. Detection of Ki-ras gene point mutations in bile specimens for the differential diagnosis of malignant and benign biliary strictures.
Saurin JC; Joly-Pharaboz MO; Pernas P; Henry L; Ponchon T; Madjar JJ
Gut; 2000 Sep; 47(3):357-61. PubMed ID: 10940271
[TBL] [Abstract][Full Text] [Related]
6. K-ras codon 12 mutations in biliary tract tumors detected by polymerase chain reaction denaturing gradient gel electrophoresis.
Imai M; Hoshi T; Ogawa K
Cancer; 1994 Jun; 73(11):2727-33. PubMed ID: 8194013
[TBL] [Abstract][Full Text] [Related]
7. Rapid detection of K-ras mutations in bile by peptide nucleic acid-mediated PCR clamping and melting curve analysis: comparison with restriction fragment length polymorphism analysis.
Chen CY; Shiesh SC; Wu SJ
Clin Chem; 2004 Mar; 50(3):481-9. PubMed ID: 14718395
[TBL] [Abstract][Full Text] [Related]
8. K-ras point mutations in the supernatants of pancreatic juice and bile are reliable for diagnosis of pancreas and biliary tract carcinomas complementary to cytologic examination.
Yamashita K; Kida Y; Shinoda H; Kida M; Okayasu I
Jpn J Cancer Res; 1999 Feb; 90(2):240-8. PubMed ID: 10189896
[TBL] [Abstract][Full Text] [Related]
9. Use of microsatellite marker loss of heterozygosity in accurate diagnosis of pancreaticobiliary malignancy from brush cytology samples.
Khalid A; Pal R; Sasatomi E; Swalsky P; Slivka A; Whitcomb D; Finkelstein S
Gut; 2004 Dec; 53(12):1860-5. PubMed ID: 15542529
[TBL] [Abstract][Full Text] [Related]
10. [Frequency of K-ras mutation in biliary and pancreatic tumors].
Roa JC; Anabalón L; Tapia O; Melo A; de Aretxabala X; Roa I
Rev Med Chil; 2005 Dec; 133(12):1434-40. PubMed ID: 16446870
[TBL] [Abstract][Full Text] [Related]
11. Relation between K-ras codon 12 mutation and p53 protein overexpression in gallbladder cancer and biliary ductal epithelia in patients with pancreaticobiliary maljunction.
Masuhara S; Kasuya K; Aoki T; Yoshimatsu A; Tsuchida A; Koyanagi Y
J Hepatobiliary Pancreat Surg; 2000; 7(2):198-205. PubMed ID: 10982614
[TBL] [Abstract][Full Text] [Related]
12. Usefulness of p53 gene mutations in the supernatant of bile for diagnosis of biliary tract carcinoma: comparison with K- ras mutation.
Wang Y; Yamaguchi Y; Watanabe H; Ohtsubo K; Wakabayashi T; Sawabu N
J Gastroenterol; 2002; 37(10):831-9. PubMed ID: 12424567
[TBL] [Abstract][Full Text] [Related]
13. Detection of mutated c-Ki-ras in the bile of patients with pancreatic cancer.
Abbruzzese JL; Evans DB; Raijman I; Larry L; King T; Leach SD; Frazier ML
Anticancer Res; 1997; 17(2A):795-801. PubMed ID: 9137410
[TBL] [Abstract][Full Text] [Related]
14. Can K-ras codon 12 mutations be used to distinguish benign bile duct proliferations from metastases in the liver? A molecular analysis of 101 liver lesions from 93 patients.
Hruban RH; Sturm PD; Slebos RJ; Wilentz RE; Musler AR; Yeo CJ; Sohn TA; van Velthuysen ML; Offerhaus GJ
Am J Pathol; 1997 Oct; 151(4):943-9. PubMed ID: 9327727
[TBL] [Abstract][Full Text] [Related]
15. K-ras codon 12 and p53 mutations in biopsy specimens and bile from biliary tract cancers.
Itoi T; Takei K; Shinohara Y; Takeda K; Nakamura K; Horibe T; Sanada A; Ohno H; Matsubayashi H; Saito T; Watanabe H
Pathol Int; 1999 Jan; 49(1):30-7. PubMed ID: 10227722
[TBL] [Abstract][Full Text] [Related]
16. Common occurrence of multiple K-RAS mutations in pancreatic cancers with associated precursor lesions and in biliary cancers.
Laghi L; Orbetegli O; Bianchi P; Zerbi A; Di Carlo V; Boland CR; Malesci A
Oncogene; 2002 Jun; 21(27):4301-6. PubMed ID: 12082617
[TBL] [Abstract][Full Text] [Related]
17. K-ras point mutations in cancerous and noncancerous biliary epithelium in patients with pancreaticobiliary maljunction.
Matsubara T; Sakurai Y; Sasayama Y; Hori H; Ochiai M; Funabiki T; Matsumoto K; Hirono I
Cancer; 1996 Apr; 77(8 Suppl):1752-7. PubMed ID: 8608574
[TBL] [Abstract][Full Text] [Related]
18. Diagnosis of pancreatic cancer by K-ras point mutation and cytology of pancreatic juice.
Uehara H; Nakaizumi A; Baba M; Iishi H; Tatsuta M; Kitamura T; Ohigashi H; Ishikawa O; Takenaka A; Ishiguro S
Am J Gastroenterol; 1996 Aug; 91(8):1616-21. PubMed ID: 8759672
[TBL] [Abstract][Full Text] [Related]
19. Clinical value of K-ras codon 12 analysis and endobiliary brush cytology for the diagnosis of malignant extrahepatic bile duct stenosis.
Sturm PD; Rauws EA; Hruban RH; Caspers E; Ramsoekh TB; Huibregtse K; Noorduyn LA; Offerhaus GJ
Clin Cancer Res; 1999 Mar; 5(3):629-35. PubMed ID: 10100716
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic and prognostic value of incidence of K-ras codon 12 mutations in resected distal bile duct carcinoma.
Rijken AM; van Gulik TM; Polak MM; Sturm PD; Gouma DJ; Offerhaus GJ
J Surg Oncol; 1998 Jul; 68(3):187-92. PubMed ID: 9701213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
